Sarah Psutka, MD
Urology · Seattle, WANPI 1235334897
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,741 of the $39,526 with a category attached, or 93.0%. Janssen Research & Development, LLC accounts for 75.5% of it on its own, with 6 other manufacturers making up the rest. Among urology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $1097.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$30K
- Merck$4K
- Johnson & Johnson$4K
- E.r. Squibb & Sons, L.L.C.$2K
- Photocure Inc$171
- Janssen Scientific Affairs, LLC$96
- plus $86 from 1 others
Across 11 payments — averaging $13,266 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$146K
What the payments were for
- Consulting fees$36,74193%
- Speaking & faculty fees$1,7504%
- Food & beverage$1,0353%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 19 | $29,844 |
| Merck | 2 | $3,908 |
| Johnson & Johnson | 11 | $3,671 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,750 |
| Photocure Inc | 1 | $171 |
| Janssen Scientific Affairs, LLC | 1 | $96 |
| Pfizer | 1 | $86 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,526 in reported general payments places this provider in the 90th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $6,869 |
| Tamsulosin Hcl | 108 | $2,516 |
| Finasteride | 69 | $1,016 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $727 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $236 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $52 |
Paid to pharmacies, not to this prescriber.
Other urology in Seattle
- James PorterSeattle$471K
- Marah HehemannSeattle$213K
- Thomas WalshSeattle$186K
- Alvaro LucioniSeattle$148K
- Una LeeSeattle$116K
- George SchadeSeattle$78K
- Vi NguyenSeattle$53K
- Rogerio HuangSeattle$45K
- Cristopher GarlitzSeattle$45K
- Daniel LinSeattle$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.